Dr. Wallmark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6420 Rockledge Dr
Ste 4200
Bethesda, MD 20817Phone+1 301-424-6231Fax+1 301-294-4648
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1995 - 1998
University of North Carolina HospitalsResidency, Internal Medicine, 1992 - 1995
Drexel University College of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1998 - 2025
FL State Medical License 2018 - 2020
PA State Medical License 1995 - 1998
NC State Medical License 1992 - 1995- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Sep 16
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
Publications & Presentations
PubMed
- 198 citationsSafety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinomaBert H. O'Neil, John M. Wallmark, David Lorente, Elena Elez, Judith Raimbourg
Plos One. 2017-12-28
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
